May 9, 2018 / 11:20 AM / 4 months ago

BRIEF-Recro Pharma Reports Q1 Loss Per Share Of $0.65

May 9 (Reuters) - Recro Pharma Inc:

* RECRO PHARMA REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

* Q1 LOSS PER SHARE $0.65

* Q1 REVENUE $19.5 MILLION VERSUS I/B/E/S VIEW $17.7 MILLION

* Q1 EARNINGS PER SHARE VIEW $-0.70 -- THOMSON REUTERS I/B/E/S

* AS OF MARCH 31, 2018, RECRO HAD CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS OF $51.3 MILLION

* REAFFIRMS ITS 2018 CDMO GUIDANCE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below